Clinical Trial Update: Optimal Intravesical Lidocaine Volume for Pain Relief During Office Intra-detrusor Onabotulinum Toxin a Injections [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating the optimal intravesical lidocaine volume for pain relief during office intradetrusor injections of OnabotulinumtoxinA in patien…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurogenic Bladder
• Overactive Bladder

Drugs mentioned

• Lidocaine (Lidocaine)
• OnabotulinumtoxinA (botulinum toxin type A)

Snippet

Sponsor: University of Louisville | Conditions: Overactive Bladder, Overactive Bladder Syndrome | Phase 4 | Status: NOT_YET_RECRUITING